Advertisement

Moderate consumption of beer reduces liver triglycerides and aortic cholesterol deposit in LDLr−/− apoB100/100 mice

      Abstract

      This study was designed to address the effects of a moderate consumption of beer on serum and liver lipid parameters and on the development of aortic lesions in a mouse model associated with a human atherogenic lipoprotein profile. LDLr−/− apoB100/100 mice received each day during 12 weeks either water, mild beer (0.570 g of ethanol/kg of body weight) or ethanol-free beer in a single pure dose. Serum and liver lipid parameters were analyzed and atherosclerotic lesions were estimated in heart and aorta through their total cholesterol content. mRNA levels of enzymes and receptors involved in lipoprotein uptake, in fatty acid esterification and oxidation, and in reverse cholesterol transport were also measured in the liver. Serum glucose, triglyceride (TG) and cholesterol levels were altered neither by ethanol-free beer nor by mild beer. Nevertheless, both beer treatments significantly increased HDL-cholesterol (HDL-C) and VLDL-C levels by reference to controls with no change in LDL-C levels. Liver TG contents were significantly decreased by either beer treatment. Cholesterol accumulation was attenuated in the whole aorta of mice treated with mild beer at p < 0.05 and not significantly with ethanol-free beer. Heart cholesterol contents were comparable in the three series. Among the genes studied, only scavenger receptor-B1 was downregulated by both beer-based beverages. LDL receptor related protein, lecithin–cholesterol acyltransferase and sterol regulatory element-binding protein 2 were downregulated only by mild beer. The expression of other genes assayed was not altered. When administered in chronic and moderate dose, unidentified components of beer may exert beneficial effects towards atherosclerosis development through alteration of lipoprotein metabolism in LDLr−/− apoB100/100 mice. This effect was slightly amplified by the presence of ethanol in beer.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hashimoto Y.
        • Futamura A.
        • Nakarai H.
        • Nakahara K.
        Effects of the frequency of alcohol intake on risk factors for coronary heart disease.
        Eur J Epidemiol. 2001; 17: 307-312
        • Rimm E.B.
        • Klatsky A.
        • Grobbee D.
        • Stampfer M.J.
        Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits.
        BMJ. 1996; 312: 731-736
        • Manach C.
        • Mazur A.
        • Scalbert A.
        Polyphenols and prevention of cardiovascular diseases.
        Curr Opin Lipidol. 2005; 16: 77-84
        • Miura Y.
        • Hosono M.
        • Oyamada C.
        • et al.
        Dietary isohumulones, the bitter components of beer, raise plasma HDL-cholesterol levels and reduce liver cholesterol and triacylglycerol contents similar to PPARalpha activations in C57BL/6 mice.
        Br J Nutr. 2005; 93: 559-567
        • Wu J.M.
        • Wang Z.R.
        • Hsieh T.C.
        • et al.
        Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine.
        Int J Mol Med. 2001; 8: 3-17
        • Sanan D.A.
        • Newland D.L.
        • Tao R.
        • et al.
        Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein (a).
        Proc Natl Acad Sci USA. 1998; 95: 4544-4549
        • Folch J.
        • Lees M.
        • Sloane Stanley G.H.
        A simple method for the isolation and purification of total lipides from animal tissues.
        J Biol Chem. 1957; 226: 497-509
        • Christie W.W.
        A simple procedure for rapid transmethylation of glycerolipids and cholesteryl esters.
        J Lipid Res. 1982; 23: 1072-1075
        • Niot I.
        • Gresti J.
        • Boichot J.
        • et al.
        Effect of dietary n-3 and n-6 polyunsaturated fatty acids on lipid-metabolizing enzymes in obese rat liver.
        Lipids. 1994; 29: 481-489
        • Kieft K.A.
        • Bocan T.M.
        • Krause B.R.
        Rapid on-line determination of cholesterol distribution among plasma lipoproteins after high-performance gel filtration chromatography.
        J Lipid Res. 1991; 32: 859-866
        • Weissbach H.
        • Robertson A.V.
        • Witkop B.
        • Udenfriend S.
        Rapid spectrophotometric assays for snake venom l-amino acid oxidase based on the oxidation of l-kynurenine or 3,4-dehydro-l-proline.
        Anal Biochem. 1960; 1: 286-290
        • Smith P.K.
        • Krohn R.I.
        • Hermanson G.T.
        • et al.
        Measurement of protein using bicinchoninic acid.
        Anal Biochem. 1985; 150: 76-85
        • Chomczynski P.
        • Sacchi N.
        Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction.
        Anal Biochem. 1987; 162: 156-159
        • Nishiwaki M.
        • Ishikawa T.
        • Ito T.
        • et al.
        Effects of alcohol on lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, and lecithin:cholesterol acyltransferase in high-density lipoprotein cholesterol elevation.
        Atherosclerosis. 1994; 111: 99-109
        • Savolainen M.J.
        • Kesaniemi Y.A.
        Effects of alcohol on lipoproteins in relation to coronary heart disease.
        Curr Opin Lipidol. 1995; 6: 243-250
        • Acton S.
        • Rigotti A.
        • Landschulz K.T.
        • et al.
        Identification of scavenger receptor SR-BI as a high density lipoprotein receptor.
        Science. 1996; 271: 518-520
        • Eisenberg S.
        High density lipoprotein metabolism.
        J Lipid Res. 1984; 25: 1017-1058
        • Fielding C.J.
        • Fielding P.E.
        Molecular physiology of reverse cholesterol transport.
        J Lipid Res. 1995; 36: 211-228
        • Furbee Jr., J.W.
        • Sawyer J.K.
        • Parks J.S.
        Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice.
        J Biol Chem. 2002; 277: 3511-3519
        • Hoeg J.M.
        • Santamarina-Fojo S.
        • Berard A.M.
        • et al.
        Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.
        Proc Natl Acad Sci USA. 1996; 93: 11448-11453
        • Vaziri N.D.
        • Liang K.
        • Parks J.S.
        Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure.
        Kidney Int. 2001; 59: 2192-2196
        • Brousseau M.E.
        • Kauffman R.D.
        • Herderick E.E.
        • et al.
        LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits.
        Arterioscler Thromb Vasc Biol. 2000; 20: 450-458
        • Meegalla R.L.
        • Billheimer J.T.
        • Cheng D.
        Concerted elevation of acyl-coenzyme A:diacylglycerol acyltransferase (DGAT) activity through independent stimulation of mRNA expression of DGAT1 and DGAT2 by carbohydrate and insulin.
        Biochem Biophys Res Commun. 2002; 298: 317-323
        • Escola-Gil J.C.
        • Calpe-Berdiel L.
        • Ribas V.
        • Blanco-Vaca F.
        Moderate beer consumption does not change early or mature atherosclerosis in mice.
        Nutr J. 2004; 3: 1
        • Kuipers F.
        • Jong M.C.
        • Lin Y.
        • et al.
        Impaired secretion of very low density lipoprotein–triglycerides by apolipoprotein E-deficient mouse hepatocytes.
        J Clin Invest. 1997; 100: 2915-2922
        • Mensenkamp A.R.
        • Jong M.C.
        • van Goor H.
        • et al.
        Apolipoprotein E participates in the regulation of very low density lipoprotein–triglyceride secretion by the liver.
        J Biol Chem. 1999; 274: 35711-35718
        • Willnow T.E.
        • Sheng Z.
        • Ishibashi S.
        • Herz J.
        Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist.
        Science. 1994; 264: 1471-1474
        • Llorente-Cortes V.
        • Otero-Vinas M.
        • Sanchez S.
        • Rodriguez C.
        • Badimon L.
        Low-density lipoprotein upregulates low-density lipoprotein receptor-related protein expression in vascular smooth muscle cells: possible involvement of sterol regulatory element binding protein-2-dependent mechanism.
        Circulation. 2002; 106: 3104-3110
        • Oka K.
        • Ishimura-Oka K.
        • Chu M.J.
        • et al.
        Mouse very-low-density-lipoprotein receptor (VLDLR) cDNA cloning, tissue-specific expression and evolutionary relationship with the low-density-lipoprotein receptor.
        Eur J Biochem. 1994; 224: 975-982
        • Brooks-Wilson A.
        • Marcil M.
        • Clee S.M.
        • et al.
        Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency.
        Nat Genet. 1999; 22: 336-345
        • Oram J.F.
        • Vaughan A.M.
        ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins.
        Curr Opin Lipidol. 2000; 11: 253-260
        • Thuren T.
        Hepatic lipase and HDL metabolism.
        Curr Opin Lipidol. 2000; 11: 277-283
        • Wang N.
        • Silver D.L.
        • Thiele C.
        • Tall A.R.
        ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein.
        J Biol Chem. 2001; 276: 23742-23747